Peregrine Pharmaceuticals shares owned by Aristotle Capital Boston
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Aristotle Capital Boston
from 13F filings
Historical chart of Aristotle Capital Boston investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Aristotle Capital Boston consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Aristotle Capital Boston
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $6.4M | 675k | 9.44 |
| 2023-06-30 | $9.2M | 661k | 13.97 |
| 2023-03-31 | $13M | 667k | 18.76 |
| 2022-12-31 | $9.1M | 658k | 13.77 |
| 2022-09-30 | $13M | 672k | 19.12 |
| 2022-06-30 | $11M | 712k | 15.26 |
| 2022-03-31 | $10M | 493k | 20.37 |
| 2021-12-31 | $13M | 458k | 29.18 |
| 2021-09-30 | $9.9M | 458k | 21.57 |
| 2021-06-30 | $12M | 461k | 25.65 |
| 2021-03-31 | $8.7M | 479k | 18.23 |
| 2020-12-31 | $5.5M | 473k | 11.54 |
| 2020-09-30 | $875k | 115k | 7.62 |